Brief: Akeso Posts HY Profit Attributable RMB2.53 Billion
29/08/2023 16:11
Aug 29 (Reuters) - Akeso Inc 9926.HK :
* HY PROFIT ATTRIBUTABLE RMB2.53 BILLION VERSUS LOSS
RMB630.4
MILLION
* HY REVENUE RMB3.68 BILLION VERSUS RMB163.1 MILLION
* NO DIVIDEND HAS BEEN PAID OR DECLARED BY THE COMPANY
DURING THE
SIX MONTHS ENDED 30 JUNE 2023
Source text for Eikon: ID:nHKS9CgZ6P
Further company coverage: 9926.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akeso
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Akeso drops most in nearly three months on discounted share sale
Brief: Akeso To Place 20 Million New Shares At HK$97.76 Per Share
Factbox: Major drugmakers turn to China for licensing deals